MedPath
HSA Approval

SotaHexal 80mg Tablet

SIN13311P

SotaHexal 80mg Tablet

SotaHexal 80mg Tablet

July 3, 2007

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C07AA07

sotalol

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Salutas Pharma GmbH

Active Ingredients

Sotalol Hydrochloride

80mg

Sotalol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SotaHexal 80mg Tablet - HSA Approval | MedPath